Albany Molecular Research (AMRI) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Wall St ends lower for the day and week as chip selloff broadens
AMRI Announces Second Quarter 2015 Results
August 4, 2015 7:30 AM EDTALBANY, N.Y., Aug. 4, 2015 /PRNewswire/ --Â AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2015.
Highlights:
Second quarter contract revenue of $85.2 million, a 39% increase from 2014 Adjusted contract margins of 26% Second quarter adjusted diluted EPS of $0.22, including a $0.05 decrease in EPS from royalties in the current quarter Operating cash flow of $16 million"We are very pleased to present another strong financial quarter, with all our divisions achieving excellent... More
